Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Depreciation & Amortization (CF) (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Depreciation & Amortization (CF) readings, the most recent being $2000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 105.88% to $2000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $32000.0, a 21.95% decrease, with the full-year FY2025 number at $32000.0, down 44.83% from a year prior.
  • Depreciation & Amortization (CF) hit $2000.0 in Q4 2025 for Arcadia Biosciences, roughly flat from $2000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $253000.0 in Q3 2021 to a low of -$116000.0 in Q4 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $61000.0 (2023), compared with a mean of $75700.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 218.92% in 2021 and later plummeted 236.47% in 2023.
  • Arcadia Biosciences' Depreciation & Amortization (CF) stood at $192000.0 in 2021, then plummeted by 55.73% to $85000.0 in 2022, then plummeted by 236.47% to -$116000.0 in 2023, then skyrocketed by 70.69% to -$34000.0 in 2024, then soared by 105.88% to $2000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $15000.0 (Q2 2025) per Business Quant data.